Alpha Cancer Technologies is a private clinical stage biotechnology company with products under development in oncology and auto-immune disease indications.
Employees: 51-200
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Innovation... | innovation... |
Mentions in press and media 1
| Date | Title | Description |
| 26.05.2022 | Alpha Cancer Technologies Inc. Presents New Data from ACT-903 in Online Publication at the 2022 ASCO Annual Meeting | In a COLO-205 xenograft model, ACT-903 demonstrates tumor suppression, increased survival after single and multiple doses, and no signs of toxicity The incremental preclinical findings reported with ACT-903, our novel protein drug conjugate... |